FIELD: biotechnology.
SUBSTANCE: present invention relates to the field of biotechnology, specifically to recombinant protein for producing neutralizing antibodies against one or several growth factors. An artificially constructed protein molecule, according to the present invention, includes several fragments interconnected by a short peptide linker, selected from immunogen peptide and neutralizing domain of one or more human growth factors, which are mediators of cell proliferation in different cancer types.
EFFECT: invention can be used in the production of vaccines for immunotherapy of tumor diseases.
15 cl, 44 dwg, 14 ex
| Title | Year | Author | Number |
|---|---|---|---|
| RECOMBINANT PROTEINS AND THEIR THERAPEUTIC USES | 2012 |
|
RU2650574C2 |
| SELF-ASSEMBLY SYNTHETIC PROTEINS | 2014 |
|
RU2801230C2 |
| SELF-ASSEMBLING SYNTHETIC PROTEINS | 2014 |
|
RU2747857C2 |
| THERAPEUTIC COMPOSITION FOR REDUCING RESISTANCE TO TYROSINE KINASE INHIBITORS | 2016 |
|
RU2735493C2 |
| COMBINATIONS OF GROWTH-REGULATING FACTORS AND HORMONES FOR NEOPLASIA TREATMENT | 2003 |
|
RU2321422C2 |
| HUMAN ANTIBODIES TO RECEPTOR OF EPIDERMAL GROWTH FACTOR | 2005 |
|
RU2402569C2 |
| RECEPTOR ANTAGONISTS FOR TREATING METASTATIC CANCER | 2009 |
|
RU2455026C2 |
| BISPECIFIC BINDING AGENTS FOR MODULATING BIOLOGICAL ACTIVITY | 2005 |
|
RU2433831C2 |
| PDGFRα ANTIBODIES FOR TREATING SECONDARY BONE TUMOUR | 2006 |
|
RU2502523C2 |
| MEANS OF IDENTIFICATION OF TUMOURS, ACQUISITIVE TO TREATMENT BY ANTIBODIES AGAINST ErbB2 | 2003 |
|
RU2338751C2 |
